Moores Cancer Center at UC San Diego Health treats the first patient treated for cancer with a human-induced pluripotent stem cell (iPSC)-derived cell therapy called FT500. Dan Kaufman collaborated with Fate Therapeutics to bring the iPSC-derived natural killer cell cancer immunotherapy to patients.
In a study of people with nonalcoholic fatty liver disease and their twins and other close relatives, UC San Diego researchers were able to diagnose liver cirrhosis simply by analyzing a person’s stool microbes.
Researchers at University of California San Diego School of Medicine, with colleagues elsewhere, report on a novel four-year, randomized clinical trial evaluating different home-based methods to assess cognitive function and decline in participants over the age of 75.
Developing how the heart forms and brain works. How to analyze sarcasm computationally. Harnessing computers to develop campaign rhetoric across the spectrum. Halıcıoğlu Data Science Institute announced innovative undergraduate research scholarship projects…
Researchers from the University of Michigan relied on supercomputers at UC San Diego and elsewhere to help them develop detailed models to better understand how TB spreads throughout the lungs.
A new paper by UC San Diego researchers hypothesizes a possible link between cancer-causing viruses.
New preclinical data from University of California San Diego School of Medicine and Moores Cancer Center offers proof-of-principle for a combination immunotherapy that suppresses tumor growth in the liver. Current therapies for liver cancer are largely ineffective, resulting in poor outcomes.
Every year, at precisely 9 a.m., medical school graduates nationwide find out where they will spend their residencies. On Friday, the 117 members of the 2019 UC San Diego School of Medicine graduating class will be among them.
Researchers at UC San Diego School of Medicine generated a new mouse model that mimics human acne for the first time, and used it to validate the concept of “good” and “bad” acne bacteria and introduce new possibilities for targeted treatments and vaccines.